Skip to main content

Table 8 EQ-5D-5L utilities and MRB-QoL total burden score, by time point and group

From: An external pilot cluster randomised controlled trial of a theory-based intervention to improve appropriate polypharmacy in older people in primary care (PolyPrime)

 

Intervention

Control

Difference (95% CI)

Missing

n (%)

Floor effects

n (%)

Ceiling effects

n (%)

Mean

(95% CI)

Missing

n (%)

Floor effects

n (%)

Ceiling effects

n (%)

Mean (95% CI)

EQ-5D-5L

Baseline

2 (5.4)

-

6 (20.0)

0.74 (0.64, 0.83)

1 (3.3)

-

8 (21.6)

0.73 (0.65, 0.82)

0.01 (−0.11, 0.13)

 nI = 37

 nC = 30

6 months

0 (0)

-

4 (15.4)

0.75 (0.67, 0.83)

0 (0)

-

5 (23.8)

0.74 (0.63, 0.84)

0.02 (−0.11, 0.14)

 nI = 26

 nC = 21

9 months

1 (4.0)

-

-

0.72 (0.61, 0.83)

0 (0)

-

-

0.77 (0.68, 0.86)

−0.05 (−0.19, 0.08)

 nI = 25

 nC = 22

MRB-QoL

Baseline

5 (13.5)

-

2 (5.4)

23.79 (18.23, 29.35)

4 (13.3)

-

3 (10.0)

26.52 (18.75, 33.30)

−2.73 (−11.85, 6.39)

 nI = 37

 nC = 30

6 months

3 (11.5)

-

2 (7.7)

21.49 (15.12, 27.87)

7 (33.3)

-

2 (9.5)

24.71 (12.82, 36.61)

−3.22 (−15.02, 8.59)

 nI = 26

 nC = 21

9 months

2 (8.0)

-

2 (8.0)

22.44 (15.24, 29.64)

4 (18.2)

-

4 (18.2)

25.27 (15.40, 35.13)

−2.83 (−14.35, 8.70)

 nI = 25

 nC = 22

  1. nI, nC number of patients in intervention (I) and control (C) after withdrawals, CI confidence intervals